Beclomethasone dipropionate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-Chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
Drag to rotate. Structure from PubChem CID 21700.
Background
Listing
- Schedules
- Schedule 2 to 4, conditions apply
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
2 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Beclomethasone dipropionate | Aerobec autohaler, Aerobec forte autohaler, Filair, +12 more | 50 µg, 50 μg, 100, 100 μg, +5 more | 9 applicants | 29 registrations | S2 to S4conditions apply |
| Beclomethasone dipropionate, formoterol | Innuvair | inhaler | Safeline Pharmaceuticals (Pty) Ltd | 420895 | S2 to S4conditions apply |
Regulatory status
Where S2 to S4 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 2: a pharmacist can sell it directly, without a prescription. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.
Schedule S2 to S4, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Beclomethasone dipropionate
S4: Beclomethasone dipropionate
- except when intended for inhalation or nasal administration.
Consolidated Schedules 06 July 2026, line 5441
S3: Beclomethasone dipropionate
- when intended for inhalation or nasal administration, except when intended for nasal administration as an aqueous spray, other than by pressurised aerosol, and indicated for the treatment of the symptoms of seasonal allergic rhinitis (hay fever) in adults and children over 12 years of age, subject to
- when a maximum dose of 100 micrograms per nostril and a maximum daily dose of 200 micrograms of per nostril and
- when a maximum pack size of 200 doses. (S2, S4)
Consolidated Schedules 06 July 2026, lines 3170 to 3177
S2: Beclomethasone dipropionate
- when intended for nasal administration as an aqueous spray, other than by pressurised aerosol, and indicated for the treatment of the symptoms of seasonal allergic rhinitis (hay fever) in adults and children over 12 years of age, subject to
- when a maximum dose of 100 micrograms per nostril and a maximum daily dose of 200 micrograms of per nostril and
- when a maximum pack size of 200 doses. (S3, S4)
Consolidated Schedules 06 July 2026, lines 1647 to 1654
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.